Skip to navigation Skip to content



New Information Posted on Clinical Trials in MS

September 16, 2013

We are pleased to present updated information about ongoing clinical trials for MS, updated for 2013.

The following tables on specific types of clinical trials are available for download:
As of this writing, -- the clinical trials registry created by the National Institutes of Health -- lists more than 300 ongoing or planned studies. The lists posted on our Web site are just a sample of what appears on, to give people affected by MS an idea of the latest clinical research in MS. Where possible, we link to further information from our Web site,, or study information elsewhere.

Visit the Clinical Trials section of our Web site for information on studies recruiting participants and on clinical trial participation.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.